{"id":"W2416547215","doi":"10.1177/1715163515600674","title":"Individualizing drug therapy in patients with diabetes and chronic kidney disease","year":2015,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Diabetes Canada; University of Toronto","funders":"","keywords":"Medicine; Linagliptin; Alogliptin; Saxagliptin; Sitagliptin; Renal function; Kidney disease; Dialysis; Diabetes mellitus; Ramipril; Urology; Dosing; Pharmacology; Metformin; Internal medicine; Type 2 diabetes; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001314034,0.0003306561,0.0007982468,0.0006838281,0.0004604433,0.0007157114,0.0004746706,0.0008810561,0.008130874],"category_scores_gemma":[0.006345148,0.0001462973,0.0006397899,0.0008117673,0.0001953568,0.000976323,0.0006719659,0.001712825,0.002217557],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007036378,"about_ca_system_score_gemma":0.002402412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003573876,"about_ca_topic_score_gemma":0.01093288,"domain_scores_codex":[0.9987621,0.0004437888,0.0002442783,0.00009669814,0.000360656,0.00009241955],"domain_scores_gemma":[0.9977851,0.0007819252,0.0006247206,0.00007174927,0.0004333734,0.0003031817],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002154922,0.0001876301,0.01475758,0.002650348,0.00009140088,0.000677755,0.0002564474,0.0002536256,0.0004144652,0.0007966206,0.2407108,0.7389879],"study_design_scores_gemma":[0.0004499537,0.0006537442,0.07614628,0.01317874,0.0002829372,0.005343684,0.000650438,0.0006667112,0.0006509304,0.004466085,0.8974462,0.00006430483],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.03265563,0.5627921,0.007852457,0.1792423,0.007168977,0.001712715,0.002084406,0.0008607184,0.2056307],"genre_scores_gemma":[0.1938223,0.620885,0.03222493,0.09521442,0.01158533,0.001731866,0.002384567,0.0001453358,0.04200636],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.008130874,"threshold_uncertainty_score":0.02720052,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02234575842571333,"score_gpt":0.2445276241499242,"score_spread":0.2221818657242109,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}